Volume 93, Issue S255
ABS15-0037
Free Access

Migration of lens epithelial cells and IOL drug soaking

C. Wertheimer

C. Wertheimer

Ophthalmology, University Eyeclinic Munich, Munich, Germany

Search for more papers by this author
A. Kueres

A. Kueres

Ophthalmology, University Eyeclinic Munich, Munich, Germany

Search for more papers by this author
W. Mayer

W. Mayer

Ophthalmology, University Eyeclinic Munich, Munich, Germany

Search for more papers by this author
R. Liegl

R. Liegl

Ophthalmology, University Eyeclinic Munich, Munich, Germany

Search for more papers by this author
K. Eibl-Lindner

K. Eibl-Lindner

Ophthalmology, University Eyeclinic Munich, Munich, Germany

Search for more papers by this author
First published: 23 September 2015

Summary

Purpose

To assess the effect of EGFR Inhibitor Erlotinib and the downstream Inhibitor Erufosin (PI3K) soaked into intraocular lenses (IOLs) on human lensepithelialcell (LEC) proliferation in vitro.

Methods

Foldable IOLs were incubated with Erufosin or Erlotinib. Intraocular lenses of the same lot served as uncoated controls. Each IOL was placed into cell cultre containing proliferating human LECs. Cell survival was tested by the XTT-dye reduction assay 5 days later. Furthermore IOLs were put into the Gotoh anterior chamber model. In addition, soaked IOLs were implanted into the human capsular bags and braught to cell-culture. The time until full cell-coverage of the capsular bag was measured.

Results

Erufosin (P<0.05) and Erlotinib (P<0.05) coated IOLs attenuated human LEC proliferation in all above described models. For both substances soaked hydrophilic acrylic IOLs were more effective inhibitors of human LEC proliferation than coated hydrophobic acrylic.

Conclusions

Results show that both substances are suitable agents for IOL-soaking without linker molecules. Soaked IOLs can inhibit human LEC proliferation in our models and might become of clinical relevance in future.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.